Surprisingly, during the last decade, not a single article reported a study about the involvement of NPRL3 in cancer and drug resistance, even if in the COSMIC database there are almost three times more somatic cancer mutations listed for NPRL3 than for its paralogue NPRL2. Here, NPRL2 is linked to cancer.